Stage II lung adenocarcinoma with a fetal-type component treated with surgery

This lung cancer diagnosis at a glance

Stage at diagnosis
Stage II
Subtype
Adenocarcinoma
Biomarkers
PD-L1 negative; no alterations identified on Oncomine Dx testing
Sex
male
Treatment
surgery
Outcome
Cancer-Free / NED

Treatment course, step by step

  1. Underwent left upper lobectomy with mediastinal lymph-node dissection for the invasive lung adenocarcinoma and a synchronous small adenocarcinoma in situ.

What happened, in summary

A 75-year-old man was evaluated for a 43 mm left upper-lung nodule without obvious distant spread. He underwent a left upper lobectomy with mediastinal lymph-node dissection. Pathology found two lung tumors in the resected lobe: an invasive adenocarcinoma and a much smaller adenocarcinoma in situ. The invasive cancer had papillary, lepidic and fetal-type areas, and a lobar bronchial lymph node contained metastasis from the fetal-type component. The invasive tumor was classified as Stage II. Molecular testing with the Oncomine Dx panel did not identify a targetable alteration, and PD-L1 testing was negative. No additional anticancer treatment was described after surgery. At 8 months of follow-up, he was doing well and had no evidence of recurrence. The two lesions are kept together because they were synchronous, removed in the same operation, and managed as one integrated lung-cancer episode.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar lung cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more lung cancer stories